Connect to MCP

Claude DesktopClaude Code (CLI)ChatGPTCursorVS Code

Nanollose Valuation Multiples

Discover revenue and EBITDA valuation multiples for Nanollose.

Start Free TrialSee companies similar to Nanollose

Nanollose Overview

About Nanollose

Nanollose Ltd is a biomaterials company, commercialising technology to create fibres, fabrics, and other materials with minimal environmental impact. Its principal activities include research and development, and promotion of the Company’s microbial cellulose technologies. The company is engaged in development and commercialization of its Tree-Free rayon fibre for use in textiles (Nullarbor) and non-woven applications (Nufolium).

Founded

2014

HQ

Australia

Employees

N/A

Financials (FY)

Revenue: $9K
EBITDA: ($776K)

EV

$22M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Nanollose Financials

Nanollose reported last fiscal year revenue of $9K and negative EBITDA of ($776K).

In the same fiscal year, Nanollose generated $9K in gross profit, ($776K) in EBITDA losses, and had net loss of ($817K).

Nanollose P&L

In the most recent fiscal year, Nanollose reported revenue of $9K and EBITDA of ($776K).

Nanollose is unprofitable as of last fiscal year, with gross margin of 100%, EBITDA margin of (8789%), and net margin of (9252%).

See analyst estimates for Nanollose
Last FY202320242025202620272028
Revenue$9K$18K$9K-
Gross Profit$9K$18K$9K-
Gross Margin100%100%100%-
EBITDA($776K)($850K)($867K)($958K)
EBITDA Margin(8789%)(4756%)(9817%)-
EBIT Margin(11577%)(5912%)(12327%)-
Net Profit($817K)($884K)($912K)($1M)
Net Margin(9252%)(4945%)(10331%)-

Financial data powered by Morningstar, Inc.

Nanollose Stock Performance

Nanollose has current market cap of $22M, and enterprise value of $22M.

Nanollose's stock price is $0.05.

See more trading valuation data for Nanollose
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$22M$22M-0.0%---$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Nanollose Valuation Multiples

Nanollose trades at 2451.5x EV/Revenue multiple, and (27.9x) EV/EBITDA.

See NTM and 2027E valuation multiples for Nanollose

Nanollose Financial Valuation Multiples

As of August 14, 2026, Nanollose has market cap of $22M and EV of $22M.

Nanollose has a P/E ratio of (26.5x).

Last FY202320242025202620272028
EV/Revenuen/mn/mn/m-
EV/EBITDA(27.9x)(25.5x)(25.0x)(22.6x)
EV/EBIT(21.2x)(20.5x)(19.9x)(18.7x)
EV/Gross Profitn/mn/mn/m-
P/E(26.5x)(24.5x)(23.7x)(21.5x)
EV/FCF(34.0x)(32.1x)(30.7x)(27.9x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Nanollose Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Nanollose Margins & Growth Rates

In the most recent fiscal year, Nanollose reported gross margin of 100%, EBITDA margin of (8789%), and net margin of (9252%).

See estimated margins and future growth rates for Nanollose

Nanollose Margins

Last FY2024202720282029
Gross Margin100%100%
EBITDA Margin(8789%)(9817%)
EBIT Margin(11577%)(12327%)
Net Margin(9252%)(10331%)
FCF Margin(7207%)(7997%)

Nanollose Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(51%)-
Gross Profit Growth(51%)-
EBITDA Growth2%10%
EBIT Growth3%6%
Net Profit Growth3%10%
FCF Growth5%10%

Data powered by FactSet, Inc. and Morningstar, Inc.

Nanollose Operational KPIs

Access forward-looking KPIs for Nanollose
Last FY20232024202620272028
G&A Expenses to Revenue4801%2604%5397%
R&D Expenses to Revenue2891%1414%2592%
Opex to Revenue11677%6012%12377%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Digital TherapeuticsHorizontal MarketplacesInvestment BankingERP SoftwareDeveloper ToolsConsumer SaaSStreamingVertical SaaSNetworking HardwareFinancial Data & InformationEnergy StorageRoad InfrastructureSemiconductors
Explore Valuation Multiples by Industry

Nanollose Competitors

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E

This data is available for Pro users. Sign up to see all Nanollose competitors and their valuation data.

Start Free Trial

Nanollose VC Funding History

Before going public, Nanollose raised $5M in total equity funding, across 1 round.

Nanollose Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Sep-17Series A-$5M-Nanollose Limited is an Australian biotechnology company developing sustainable fibre technology based on cellulose derived from bacterial sources. The company's primary technology, Nanollose Technologies, has applications in textiles, horticulture, medical, hygiene, paper, packaging, and food industries. In preparation for an Australian Securities Exchange (ASX) listing expected in October 2017, Nanollose raised Au$5 million from investors to advance commercialization efforts. The capital was allocated toward a two-year research and development program, with approximately Au$2.2 million directed to product research and development, Au$0.4 million to intellectual property protection, and Au$0.4 million to customer engagement and marketing. The company focused on developing Nanollose Technologies for use in textile applications and as a horticultural substrate for seed germination as an alternative to traditional soil and seed-raising mixtures.

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Nanollose

When was Nanollose founded?Nanollose was founded in 2014.
Where is Nanollose headquartered?Nanollose is headquartered in Australia.
Is Nanollose publicly listed?Yes, Nanollose is a public company listed on Australian Securities Exchange.
What is the stock symbol of Nanollose?Nanollose trades under NC6 ticker.
When did Nanollose go public?Nanollose went public in 2017.
Who are competitors of Nanollose?Nanollose main competitors include
What is the current market cap of Nanollose?Nanollose's current market cap is $22M.
What is the current revenue of Nanollose?Nanollose's last fiscal year revenue is $9K.
What is the current EV/Revenue multiple of Nanollose?Current revenue multiple of Nanollose is 2451.5x.
Is Nanollose profitable?No, Nanollose is not profitable.
How many companies Nanollose has acquired to date?Nanollose hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Nanollose has invested to date?Nanollose hasn't invested in any companies yet (or none have been disclosed publicly).

Lists including Nanollose

Largest Companies in Australia

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial